Saiqi Wang

1.7k total citations · 1 hit paper
56 papers, 1.3k citations indexed

About

Saiqi Wang is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Saiqi Wang has authored 56 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 17 papers in Oncology and 9 papers in Organic Chemistry. Recurrent topics in Saiqi Wang's work include Cancer therapeutics and mechanisms (10 papers), Synthesis and biological activity (8 papers) and Gastric Cancer Management and Outcomes (7 papers). Saiqi Wang is often cited by papers focused on Cancer therapeutics and mechanisms (10 papers), Synthesis and biological activity (8 papers) and Gastric Cancer Management and Outcomes (7 papers). Saiqi Wang collaborates with scholars based in China, United States and New Zealand. Saiqi Wang's co-authors include Xiaobing Chen, Hong‐Min Liu, Xiaobing Chen, Bin Yu, Huifang Lv, Shuai Wang, Hong‐Min Liu, Liying Ma, Xiaohan Yuan and Yi‐Chao Zheng and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Scientific Reports.

In The Last Decade

Saiqi Wang

51 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Application and synthesis of thiazole ring in clinically approved drugs

2023 109 citations Xiaobing Chen, Saiqi Wang et al. European Journal of Medicinal Chemistry profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Saiqi Wang China	19	582	462	338	156	141	56	1.3k
Ramesh Ummanni India	25	756 1.3×	494 1.1×	167 0.5×	164 1.1×	231 1.6×	64	1.6k
Ningyu Wang China	22	918 1.6×	338 0.7×	307 0.9×	90 0.6×	95 0.7×	84	1.5k
Jean‐Marc Barret France	20	905 1.6×	225 0.5×	375 1.1×	64 0.4×	117 0.8×	43	1.3k
Aranapakam M. Venkatesan United States	22	785 1.3×	523 1.1×	158 0.5×	135 0.9×	55 0.4×	40	1.4k
Mirela Sedić Croatia	18	514 0.9×	705 1.5×	136 0.4×	45 0.3×	111 0.8×	49	1.3k
Vikas Bhardwaj United States	18	427 0.7×	172 0.4×	181 0.5×	85 0.5×	266 1.9×	37	861
Yasuhide Hirota Japan	13	1.1k 1.9×	197 0.4×	766 2.3×	111 0.7×	119 0.8×	21	1.5k
Robert C.A.M. van Waardenburg United States	20	860 1.5×	144 0.3×	589 1.7×	71 0.5×	100 0.7×	38	1.2k
Céline Loncle France	18	613 1.1×	302 0.7×	426 1.3×	62 0.4×	274 1.9×	25	1.3k
Wenhua Lu China	22	727 1.2×	178 0.4×	283 0.8×	115 0.7×	412 2.9×	65	1.4k

Countries citing papers authored by Saiqi Wang

Since Specialization

Citations

This map shows the geographic impact of Saiqi Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Saiqi Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Saiqi Wang more than expected).

Fields of papers citing papers by Saiqi Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Saiqi Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Saiqi Wang. The network helps show where Saiqi Wang may publish in the future.

Co-authorship network of co-authors of Saiqi Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Saiqi Wang. A scholar is included among the top collaborators of Saiqi Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Saiqi Wang. Saiqi Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hu, Hui-Hui, Huifang Lv, Jianzheng Wang, et al.. (2025). Resibufogenin and Oxaliplatin Synergistically Inhibit Diffuse Gastric Cancer by Inactivating the FAK/AKT/GSK3β/β-Catenin Signaling Pathway. Recent Patents on Anti-Cancer Drug Discovery. 21(1). 14–30.

Zhao, Lidan, Wenhui Qiu, A. Lu, et al.. (2025). Inhibition of Skp2 enhances anti-tumor immunity of macrophages by regulating CD47 in gastric cancer. International Immunopharmacology. 163. 115262–115262. 1 indexed citations

Dai, Xing‐Jie, Huimin Liu, Shaopeng Wang, et al.. (2024). Degraders in epigenetic therapy: PROTACs and beyond. Theranostics. 14(4). 1464–1499. 23 indexed citations

Wang, Shuwu, Ying Zhou, Shaopeng Wang, et al.. (2024). Discovery of 2-Aryl-4-aminoquinazolin-Based LSD1 Inhibitors to Activate Immune Response in Gastric Cancer. Journal of Medicinal Chemistry. 67(18). 16165–16184. 6 indexed citations

Wang, Shuai, Saiqi Wang, Xiaobing Chen, et al.. (2024). Cell-Based Screen Identifies a Highly Potent and Orally Available ABCB1 Modulator for Treatment of Multidrug Resistance. Journal of Medicinal Chemistry. 67(21). 18764–18780. 2 indexed citations

Hu, Hui-Hui, Saiqi Wang, Huifang Lv, et al.. (2024). Roles and inhibitors of FAK in cancer: current advances and future directions. Frontiers in Pharmacology. 15. 1274209–1274209. 38 indexed citations

Wang, Hui, Caiyun Nie, Huifang Lv, et al.. (2023). Novel GSH-responsive prodrugs derived from indole-chalcone and camptothecin trigger apoptosis and autophagy in colon cancer. Bioorganic Chemistry. 143. 107056–107056. 11 indexed citations

Nie, Caiyun, Huifang Lv, Beibei Chen, et al.. (2023). High DCR and Better Survival in Patients with Advanced or Metastatic Gastric Cancer Receiving Anti-Angiogenic TKI plus Chemotherapy: A Real-World Study. Technology in Cancer Research & Treatment. 22. 2213892449–2213892449. 1 indexed citations

Bai, Yi‐Ru, Weiguang Yang, Dandan Shen, et al.. (2023). The recent advance of Interleukin-1 receptor associated kinase 4 inhibitors for the treatment of inflammation and related diseases. European Journal of Medicinal Chemistry. 258. 115606–115606. 23 indexed citations

10.

Yuan, Shuo, Dandan Shen, Yi‐Ru Bai, et al.. (2023). Oxazolidinone: A promising scaffold for the development of antibacterial drugs. European Journal of Medicinal Chemistry. 250. 115239–115239. 32 indexed citations

11.

Wang, Saiqi, Qiu‐Xu Teng, Shuai Wang, et al.. (2022). Preclinical studies of the triazolo[1,5-a]pyrimidine derivative WS-716 as a highly potent, specific and orally active P-glycoprotein (P-gp) inhibitor. Acta Pharmaceutica Sinica B. 12(8). 3263–3280. 24 indexed citations

12.

Nie, Caiyun, Weifeng Xu, Beibei Chen, et al.. (2022). An Exploration of Trifluridine/Tipiracil Monotherapy and in Combination With Bevacizumab or Immune Checkpoint Inhibitors for Patients With Metastatic Colorectal Cancer: A Real-World Study. Clinical Colorectal Cancer. 22(1). 76–84. 6 indexed citations

13.

Xu, Weifeng, Caiyun Nie, Huifang Lv, et al.. (2022). Molecular subtypes based on Wnt-signaling gene expression predict prognosis and tumor microenvironment in hepatocellular carcinoma. Frontiers in Immunology. 13. 1010554–1010554. 7 indexed citations

14.

Wang, Shuai, Xiaohan Yuan, Saiqi Wang, et al.. (2021). FDA-approved pyrimidine-fused bicyclic heterocycles for cancer therapy: Synthesis and clinical application. European Journal of Medicinal Chemistry. 214. 113218–113218. 108 indexed citations

15.

Wang, Shuai, Saiqi Wang, Qiu‐Xu Teng, et al.. (2021). Discovery of the Triazolo[1,5-a]Pyrimidine-Based Derivative WS-898 as a Highly Efficacious and Orally Bioavailable ABCB1 Inhibitor Capable of Overcoming Multidrug Resistance. Journal of Medicinal Chemistry. 64(21). 16187–16204. 29 indexed citations

16.

Wang, Bo, Xiaojing Li, Saiqi Wang, et al.. (2021). Discovery of a cinnamyl piperidine derivative as new neddylation inhibitor for gastric cancer treatment. European Journal of Medicinal Chemistry. 226. 113896–113896. 7 indexed citations

17.

Wang, Shuai, Saiqi Wang, Qiu‐Xu Teng, et al.. (2020). Structure-Based Design, Synthesis, and Biological Evaluation of New Triazolo[1,5- a ]Pyrimidine Derivatives as Highly Potent and Orally Active ABCB1 Modulators. Journal of Medicinal Chemistry. 63(24). 15979–15996. 41 indexed citations

18.

Bie, Liangyu, Dan Li, Wei Yan, et al.. (2020). HOTAIR Competitively Binds MiRNA330 as a Molecular Sponge to Increase the Resistance of Gastric Cancer to Trastuzumab. Current Cancer Drug Targets. 20(9). 700–709. 14 indexed citations

19.

Wang, Cong, Saiqi Wang, Junwei Wang, et al.. (2017). Anti-proliferative effect of Jesridonin on paclitaxel-resistant EC109 human esophageal carcinoma cells. International Journal of Molecular Medicine. 39(3). 645–653. 3 indexed citations

20.

Shi, Xiaoli, Jin‐Ling Huo, Tiantian Qin, et al.. (2017). Targeting the Bcl-2 family and P-glycoprotein reverses paclitaxel resistance in human esophageal carcinoma cell line. Biomedicine & Pharmacotherapy. 90. 897–905. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact